Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab′)2: pharmacokinetics, tissue distribution, and tumor imaging
Open Access
- 1 January 1992
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 2 (1) , 23-34
- https://doi.org/10.1046/j.1525-1438.1992.02010023.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Secondary cytoreductive surgery for recurrent epithelial ovarian cancerPublished by Elsevier ,2014
- CA 125 and OA 3 as target antigens for immunodiagnosis and immunotherapy in ovarian cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- A prospective evaluation of OC125 and magnetic resonance imaging in patients with ovarian carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125American Journal of Obstetrics and Gynecology, 1989
- Comparison of abdominopelvic computed tomography results and findings at second-look laparotomy in ovarian carcinoma patientsCancer, 1989
- Magnetic Resonance Imaging of the Abdomen and PelvisJAMA, 1989
- The value of CT scanning in the management of patients with gynecologic malignanciesArchiv für Gynäkologie, 1989
- Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragmentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1989
- Biodistribution, pharmacokinetics and imaging of131I-labelled OC125 in ovarian cancerInternational Journal of Cancer, 1988
- Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assaysInternational Journal of Cancer, 1988